Crude OR | 95% CI | Adjusted OR | 95% CI | P | |
---|---|---|---|---|---|
Sex | |||||
Male | Reference | ||||
Female | 1.08 | 0.78–1.49 | 1.16 | 0.81–1.66 | 0.41 |
Age groups (age groups) | |||||
0–14 | Reference | ||||
15–19 | 0.79 | 0.21–2.88 | 2.02 | 0.20–20.39 | 0.55 |
20–29 | 1.06 | 0.41–2.78 | 3.06 | 0.24–38.79 | 0.39 |
30–39 | 1.58 | 0.60–4.20 | 5.50 | 0.42–71.34 | 0.19 |
40–49 | 1.41 | 0.51–3.88 | 5.01 | 0.37–67.1 | 0.22 |
50 plus | 1.02 | 0.35–2.94 | 3.58 | 0.26–49.37 | 0.34 |
Job status | |||||
Healthcare workers (HCW) | Reference | ||||
Full-time work, other than HCW | 1.17 | 0.58–2.39 | 1.29 | 0.60–2.76 | 0.51 |
Self-employed | 1.18 | 0.24–5.84 | 1.21 | 0.23–6.39 | 0.82 |
Employed on daily/temporal basis | 2.67 | 1.21–5.88 | 3.11 | 1.34–7.26 | < 0.05 |
Houseworkers | 1.43 | 0.28–7.20 | 1.12 | 0.21–5.89 | 0.89 |
Students, high school and above | 1.22 | 0.60–2.50 | 1.98 | 0.85–4.64 | 0.11 |
Secondary, primary school students, other children and infants | 1.25 | 0.43–3.64 | 4.97 | 0.42–58.75 | 0.20 |
Unemployed | 1.05 | 0.40–2.79 | 1.07 | 0.35–3.26 | 0.90 |
Others and unknown | 3.14 | 1.33–7.41 | 4.09 | 1.60–10.48 | < 0.05 |
Country of Birth | |||||
Others | Reference | ||||
the Philippines | 1.17 | 0.72–1.88 | 1.05 | 0.63–1.77 | 0.84 |
China | 0.99 | 0.59–1.65 | 0.92 | 0.54–1.57 | 0.75 |
Vietnam | 1.17 | 0.68–2.00 | 1.38 | 0.76–2.49 | 0.29 |
Nepal | 0.70 | 0.38–1.29 | 0.64 | 0.33–1.24 | 0.18 |
Indonesia | 0.87 | 0.37–2.05 | 1.19 | 0.48–2.97 | 0.71 |
Regimen | |||||
RFP monotherapy | Reference | ||||
INH monotherapy | 2.05 | 0.82–5.14 | 2.14 | 0.82–5.54 | 0.12 |
Other | 4.87 | 0.43–55.7 | 4.57 | 0.29–71.53 | 0.28 |
Health insurance | |||||
National health insurance | Reference | ||||
Social welfare | 1.49 | 0.43–5.22 | 1.85 | 0.45–7.61 | 0.39 |
Others and unknown | 1.32 | 0.64–2.73 | 1.13 | 0.53–2.43 | 0.76 |
Modes of detection | |||||
Contact investigation | Reference | ||||
Routine screening | 0.94 | 0.49–1.80 | 1.09 | 0.54–2.21 | 0.80 |
At hospital | 1.10 | 0.63–1.92 | 1.17 | 0.63–2.17 | 0.63 |
Other mass screening | 0.26 | 0.03–1.89 | 0.19 | 0.02–1.47 | 0.11 |
Others | 0.68 | 0.24–1.93 | 0.64 | 0.22–1.89 | 0.42 |
Time between entry to Japan and diagnosis | |||||
within 2 years | Reference | ||||
more than 2 years, within 5 years | 1.62 | 0.98–2.68 | 1.69 | 1.00–2.87 | 0.05 |
more than 5 years, within 10 years | 1.62 | 0.79–3.35 | 1.50 | 0.69–3.26 | 0.31 |
10 years or more | 0.98 | 0.55–1.76 | 0.85 | 0.43–1.68 | 0.65 |